Replies to post #32419 on CBA Florida Inc. (fka CBAI)

[MrLong]

Ohh boy, the possibilities could be limitless.... Pharma's Developing Interest in Stem Cells

Ruth McKernan1, , , John McNeish2 and Devyn Smith3

1 Pfizer Regenerative Medicine, Cambridge CB21 6GP, UK

2 Pfizer Regenerative Medicine, Cambridge, MA 02139, USA

3 Pfizer Strategic Management Group, New London, CT 06340, USA


Available online 3 June 2010.

Human stem cell biology is driving the promise of novel regenerative therapies into clinical trials. Although the pharmaceutical industry has embraced stem cells as tools in drug discovery, few companies have taken the risk to deliver stem cell-based medicines. Here, we evaluate the various cell-based opportunities and corporate strategies.

http://www.cell.com/cell-stem-cell/abstract/S1934-5909(10)00222-5